If you liked this article you might like

Mylan Can Focus on New Generics After EpiPen Medicaid Settlement

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Perrigo Unveils Divestitures, Says It's Open to Making Bolt-On Acquisitions

These Biotech Stocks are BOOMING

Mylan Slides on North American Sales Drop, Uncertainty over Generic Approvals